Results 201 to 210 of about 331,825 (303)
Suppression of LTBP1 enhances the sensitivity of bladder cancer to cisplatin. [PDF]
Li Z +6 more
europepmc +1 more source
Cardiovascular disease incidence and cancer risk in two large European prospective cohorts
What's New? Cardiovascular disease (CVD) and cancer share risk factors and biological mechanisms, raising questions about potential associations between the two, particularly regarding CVD duration and cancer onset. Whether CVD influences subsequent cancer risk, however, remains inconclusive.
Emma Fontvieille +25 more
wiley +1 more source
Bladder Cancer Incidence Trends in the United States From 2000 to 2020. [PDF]
Mousavi SE +7 more
europepmc +1 more source
Optimizing neoadjuvant therapy for muscle‐invasive bladder cancer patients who are eligible for cisplatin remains difficult, owing particularly to high toxicity and recurrence rates. This meta‐analysis compared dose‐dense methotrexate, vinblastine, doxorubicin, and cisplatin (ddMVAC) against durvalumab plus gemcitabine‐cisplatin (D‐GC) and GC alone ...
Maurin Helen Mangold +12 more
wiley +1 more source
The emerging role of the microbiome in bladder cancer: prognostic implications and treatment response. [PDF]
Côrtes J +2 more
europepmc +1 more source
Associations between outdoor air pollution and cancers other than lung cancer remain unclear, particularly in the context of tobacco use. Here, the authors assessed possible links between ambient air pollutant exposure and incidence of 20 non‐lung cancers among adults followed over a 25‐year period in the United States.
W. Ryan Diver +4 more
wiley +1 more source
CD39/CD73-mediated immunosuppression and tumor aggressiveness in bladder cancer. [PDF]
Furriel F +9 more
europepmc +1 more source
Bisphosphonates are widely used to treat osteoporosis and to manage bone metastases in patients with breast cancer. Nitrogen‐based bisphosphonates may also broadly reduce cancer risk, but evidence remains inconsistent. This large population‐based data linkage study in women aged > 50 years found that, compared to no use of osteoporosis medicines ...
Karen M. Tuesley +7 more
wiley +1 more source
ARIH2 Ubiquitination Regulates NUPR1 to Inhibit Ferroptosis in Bladder Cancer. [PDF]
Deng H +9 more
europepmc +1 more source
Cancer Risk in Marfan Syndrome: A Swedish Population‐Based Cohort Study
The cancer risk in Marfan syndrome, an autosomal dominant connective tissue disorder, largely remains to be explored. In this population‐based matched cohort study of 1544 Swedish patients, the overall cancer risk in adults with Marfan syndrome showed no significant increase, except for the risk of endocrine tumours with a nearly threefold increase ...
Ida Nordgren +8 more
wiley +1 more source

